James I. Healy, M.D., Ph.D.
Managing General Partner and President
Sofinnova Ventures

Dr. Healy has served as a member of the Board since April 1999 and served as the interim Chairman of the Board from October 1999 through January 2000. Dr. Healy joined Sofinnova Ventures in June 2000 as a general partner and managing director. From January 1998 through March 2000, Dr. Healy was a partner at Sanderling Ventures. During 1997, Dr. Healy was supported by a Novartis Foundation bursary award and performed research at Brigham and Women's Hospital. From 1990 to 1997, Dr. Healy was employed by the Howard Hughes Medical Institute and Stanford University. Dr. Healy currently serves on the boards of directors of Anthera Pharmaceuticals, Inc. and Amarin Corporation. Dr. Healy serves on the board of directors of several private companies. He holds a B.A. in Molecular Biology and a B.A. in Scandinavian studies, both from the University of California at Berkeley. Dr. Healy holds an M.D. and a Ph.D. from the Stanford University School of Medicine.